Viewing Study NCT00577850


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-21 @ 6:45 PM
Study NCT ID: NCT00577850
Status: COMPLETED
Last Update Posted: 2013-04-17
First Post: 2007-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
Sponsor: Warner Chilcott
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteopenia View
None Osteoporosis View
Keywords: